Transient over-expression of bioactive PDGF-BB induces lung fibrosis

J. C. Rodriguez-Lecompte, K. Ask, A. Froese, K. Linher, K. Martin, J. Gauldie (Hamilton, Canada)

Source: Annual Congress 2006 - Molecular airway biology
Session: Molecular airway biology
Session type: Oral Presentation
Number: 955
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. C. Rodriguez-Lecompte, K. Ask, A. Froese, K. Linher, K. Martin, J. Gauldie (Hamilton, Canada). Transient over-expression of bioactive PDGF-BB induces lung fibrosis. Eur Respir J 2006; 28: Suppl. 50, 955

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Transient transgene expression of CTGF in the lung induces moderate and reversible fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 378s
Year: 2002

Simultaneous inhibition of CTGF and Autotaxin reduces lung fibrosis and improves lung function in mice
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021


Follistatin-like 1 promotes intermittent hypoxia-induced lung fibroblast activation in vitro and in vivo
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Inhibition of the Arp2/3 complex inhibits lung myofibroblast differentiation in vitro and attenuates bleomycin-induced pulmonary fibrosis in mice
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019

Attenuation of bleomycin-induced pulmonary fibrosis by direct thrombin inhibition is accompanied by a reduction in connective tissue growth factor mRNA levels
Source: Eur Respir J 2001; 18: Suppl. 33, 199s
Year: 2001

Inhibition of HGF secretion by pulmonary fibroblasts from IPF: involvement of PGE2
Source: Eur Respir J 2003; 22: Suppl. 45, 8s
Year: 2003

LSC Abstract – Activation of FGF9 and 18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016

Gp130-Stat3 signalling regulates sensitivity to bleomycin induced lung fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 604s
Year: 2006

BIBF1120 inhibits fibroblasts proliferation and production of the extracellular matrix protein fibulin-1
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

6-aminonicotinamide ameliorates pulmonary fibrosis by suppressing the TGF-beta1 activated Smad signalling pathway
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020


c-Met expression induction in immune cells modulates pulmonary fibrosis progression
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020

NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into myofibroblasts
Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Year: 2009

Wnt11 inhibits effects of transforming growth factor-beta1 (TGFbeta1) on lung epithelial phenotype
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013


Cell specific gene transfer of hepatocyte growth factor reduces bleomycin-induced lung fibrosis by inhibition of partial EMT
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008

VEGF induces ECM synthesis and fibroblast activity in human lung fibroblasts
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017

Synergistic role of HSP90a and HSP90ß to promote myofibroblast persistence in lung fibrosis
Source: Eur Respir J, 51 (2) 1700386; 10.1183/13993003.00386-2017
Year: 2018



miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production
Source: Eur Respir J 2015; 46: 1350-1360
Year: 2015



Tankyrase(TNKS) inhibiting autophagy promotes the TGF-ß induced EMT process in vitro and Bleomycin(BLM) induced pulmonary fibrosis in rats
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019

Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 17: 180-189
Year: 2001



In vitro profibrotic effects of rapamycin on basal or TGF-β1 induced primary human lung fibroblast: ECM production and turnover, migration and differentiation
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012